Target Healthcare REIT (THRL) Competitors GBX 84.40 +1.20 (+1.44%) (As of 11:53 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlines THRL vs. AGR, PHP, IHR, LABS, MXF, BYG, GPOR, LXI, GRI, and SHBShould you be buying Target Healthcare REIT stock or one of its competitors? The main competitors of Target Healthcare REIT include Assura (AGR), Primary Health Properties (PHP), Impact Healthcare REIT (IHR), Life Science REIT (LABS), Medicx Fund (MXF), Big Yellow Group (BYG), Great Portland Estates (GPOR), Lxi Reit (LXI), Grainger (GRI), and Shaftesbury (SHB). These companies are all part of the "real estate" sector. Target Healthcare REIT vs. Assura Primary Health Properties Impact Healthcare REIT Life Science REIT Medicx Fund Big Yellow Group Great Portland Estates Lxi Reit Grainger Shaftesbury Target Healthcare REIT (LON:THRL) and Assura (LON:AGR) are both small-cap real estate companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, community ranking, dividends, valuation and earnings. Is THRL or AGR a better dividend stock? Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 7.1%. Assura pays an annual dividend of GBX 3 per share and has a dividend yield of 7.8%. Target Healthcare REIT pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Assura pays out -30,000.0% of its earnings in the form of a dividend. Assura is clearly the better dividend stock, given its higher yield and lower payout ratio. Do insiders and institutionals have more ownership in THRL or AGR? 69.4% of Target Healthcare REIT shares are held by institutional investors. Comparatively, 73.7% of Assura shares are held by institutional investors. 0.1% of Target Healthcare REIT shares are held by company insiders. Comparatively, 8.4% of Assura shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer THRL or AGR? Assura received 278 more outperform votes than Target Healthcare REIT when rated by MarketBeat users. Likewise, 67.21% of users gave Assura an outperform vote while only 65.03% of users gave Target Healthcare REIT an outperform vote. CompanyUnderperformOutperformTarget Healthcare REITOutperform Votes9365.03% Underperform Votes5034.97% AssuraOutperform Votes37167.21% Underperform Votes18132.79% Is THRL or AGR more profitable? Target Healthcare REIT has a net margin of 104.99% compared to Assura's net margin of -18.25%. Target Healthcare REIT's return on equity of 10.87% beat Assura's return on equity.Company Net Margins Return on Equity Return on Assets Target Healthcare REIT104.99% 10.87% 3.86% Assura -18.25%-1.88%2.82% Which has more volatility & risk, THRL or AGR? Target Healthcare REIT has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500. Comparatively, Assura has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500. Does the media refer more to THRL or AGR? In the previous week, Target Healthcare REIT had 1 more articles in the media than Assura. MarketBeat recorded 1 mentions for Target Healthcare REIT and 0 mentions for Assura. Target Healthcare REIT's average media sentiment score of 0.75 beat Assura's score of 0.67 indicating that Target Healthcare REIT is being referred to more favorably in the media. Company Overall Sentiment Target Healthcare REIT Positive Assura Positive Do analysts prefer THRL or AGR? Assura has a consensus target price of GBX 50.67, suggesting a potential upside of 31.47%. Given Assura's stronger consensus rating and higher probable upside, analysts plainly believe Assura is more favorable than Target Healthcare REIT.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Target Healthcare REIT 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Assura 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has better earnings and valuation, THRL or AGR? Target Healthcare REIT has higher earnings, but lower revenue than Assura. Assura is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTarget Healthcare REIT£69.55M7.57£73.02M£0.12707.50Assura£157.80M7.94-£28.80M-£0.01-3,854.00 SummaryAssura beats Target Healthcare REIT on 11 of the 20 factors compared between the two stocks. Ad Behind the MarketsWhy is Buffett going all in on this?Warren Buffett has increased his already massive stake in this sector by almost 30% in the past few months. Microsoft and Blackrock created a special fund worth $100 billion to boost this 'silent' bull market. Institutional investors have a combined $2.8 trillion in this sector. Despite its "bad rap", this industry stubbornly rakes in profits.Click here to learn more >>> Get Target Healthcare REIT News Delivered to You Automatically Sign up to receive the latest news and ratings for THRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THRL vs. The Competition Export to ExcelMetricTarget Healthcare REITREIT IndustryReal Estate SectorLON ExchangeMarket Cap£526.58M£1.28B£1.44B£1.40BDividend Yield6.28%7.41%7.06%11.74%P/E Ratio707.50185.87269.371,558.04Price / Sales7.57514.32902.53311,012.94Price / Cash14.3744.1457.9532.94Price / Book0.761.181.142.85Net Income£73.02M-£53.40M-£44.93M£152.80M7 Day PerformanceN/A-2.57%-1.00%18.96%1 Month Performance1.31%-3.07%-2.12%18.69%1 Year Performance1.92%0.70%3.44%23.73% Target Healthcare REIT Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THRLTarget Healthcare REITN/AGBX 84.40+1.4%N/A-0.4%£523.48M£69.55M703.33N/AAGRAssura3.1586 of 5 starsGBX 38.94-0.5%GBX 50.67+30.1%-14.4%£1.27B£157.80M-3,906.0084Positive NewsPHPPrimary Health Properties1.2032 of 5 starsGBX 92.80-0.9%GBX 107.50+15.8%-7.8%£1.24B£177.80M-9,360.0058IHRImpact Healthcare REITN/AGBX 87.30-1.1%GBX 114+30.6%-1.6%£361.75M£53.51M793.64N/ALABSLife Science REIT1.9771 of 5 starsGBX 38.10-1.0%GBX 46.50+22.0%-39.7%£133.35M£19.94M-640.00N/AMXFMedicx FundN/AGBX 96.40flatN/AN/A£0.00N/A0.00N/AHigh Trading VolumeBYGBig Yellow Group2.1341 of 5 starsGBX 972-1.4%GBX 1,343+38.2%-20.0%£1.90B£199.62M782.54503News CoverageGPORGreat Portland EstatesN/AGBX 735.50-2.0%N/AN/A£1.87B£100.70M124.66210Gap UpLXILxi ReitN/AGBX 100.80flatN/AN/A£1.72B£256.30M-458.18N/AGRIGrainger2.717 of 5 starsGBX 226.50-1.7%GBX 317.50+40.2%-15.8%£1.67B£270.30M8,183.33372News CoverageSHBShaftesburyN/AGBX 421.60+1.3%N/AN/A£1.62B£123.10M1,277.5839News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies AGR Alternatives PHP Alternatives IHR Alternatives LABS Alternatives MXF Alternatives BYG Alternatives GPOR Alternatives LXI Alternatives GRI Alternatives SHB Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:THRL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Target Healthcare REIT Please log in to your account or sign up in order to add this asset to your watchlist. Share Target Healthcare REIT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.